Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron Patch vs Ondansetron in Malignant Glioma
NCT01952886Phase 2Withdrawn
- Sponsor
- Duke University
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of granisetron in nausea ((none)) and Vomiting (2 arms), sponsored by Duke University. Primary endpoint: Satisfaction with Granisetron Transdermal Delivery System (GTDS) versus Ondansetron pill at 2 weeks. Status: withdrawn.
02
Drugs
granisetron
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT01952886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01952886.